Goetz Kathleen Insider Trades

Insider Trading History

Track insider trading activity for Goetz Kathleen. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $1.04M 63,724 shares
Last Trade
May 16, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$519k 63,724 shares
$8.15
$16.37
abrdn World Healthcare Fund
abrdn World Healthcare Fund THW
Director
Holding Value $12.7k 1,017 shares
Last Trade
Apr 09, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.51k 200 shares
$12.53
$12.50
abrdn Healthcare Opportunities Fund
abrdn Healthcare Opportunities Fund THQ
Director
Holding Value $20.6k 1,148 shares
Last Trade
Apr 09, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$11.7k 600 shares
$19.54
$17.94
abrdn Healthcare Investors
abrdn Healthcare Investors HQH
Director
Holding Value $20.8k 1,079 shares
Last Trade
Apr 09, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$8.62k 525 shares
$16.42
$19.26
abrdn Life Sciences Investors
abrdn Life Sciences Investors HQL
Director
Holding Value $18.7k 1,085 shares
Last Trade
Apr 09, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.33k 400 shares
$13.32
$17.27
abrdn World Healthcare Fund
abrdn World Healthcare Fund THW
Director
Holding Value $10.2k 817 shares
Last Trade
Mar 23, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.5k 103 shares
$14.52
$12.50
abrdn Healthcare Investors
abrdn Healthcare Investors HQH
Director
Holding Value $10.7k 554 shares
Last Trade
Mar 23, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.49k 73 shares
$20.42
$19.26
abrdn Life Sciences Investors
abrdn Life Sciences Investors HQL
Director
Holding Value $11.8k 685 shares
Last Trade
Mar 23, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.5k 92 shares
$16.27
$17.27
abrdn Healthcare Opportunities Fund
abrdn Healthcare Opportunities Fund THQ
Director
Holding Value $9.83k 548 shares
Last Trade
Mar 23, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.5k 69 shares
$21.69
$17.94
abrdn Healthcare Investors
abrdn Healthcare Investors HQH
Director
Holding Value $9.26k 481 shares
Last Trade
Jan 26, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10.4k 481 shares
$21.52
$19.26
abrdn World Healthcare Fund
abrdn World Healthcare Fund THW
Director
Holding Value $8.93k 714 shares
Last Trade
Jan 26, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10.4k 714 shares
$14.60
$12.50
abrdn Healthcare Opportunities Fund
abrdn Healthcare Opportunities Fund THQ
Director
Holding Value $8.59k 479 shares
Last Trade
Jan 26, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10.4k 479 shares
$21.73
$17.94
abrdn Life Sciences Investors
abrdn Life Sciences Investors HQL
Director
Holding Value $10.2k 593 shares
Last Trade
Jan 26, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10.4k 593 shares
$17.54
$17.27

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up